Research Article

Formulation and Evaluation of Liquisolid Compacts for Olmesartan Medoxomil

Figure 5

(a) In vitro dissolution profile for liquisolid compacts with 40% [w/w] drug concentration. (b) In vitro dissolution profile for liquisolid compacts with 20% [w/w] drug concentration.
870579.fig.005a
(a) ā€‰
870579.fig.005b
(b)